KUALA LUMPUR (Reuters) – Malaysia acquired 268,800 doses of AstraZeneca vaccines on Friday night time, its first batch from the pharmaceutical firm, state information company reported on Saturday.
Well being Minister Adham Baba stated the batch was bought by way of the COVAX facility.
“The COVAX facility despatched the vaccine from South Korea, and we’ll preserve it on the designated storage centre,” he instructed reporters, in line with Bernama.
The nation had initially given conditional approval in March for the usage of the vaccine made by the agency, however positioned it beneath overview after the European Medicines Company discovered that uncommon blood clots with low blood platelets was a uncommon facet impact of the vaccine.
Adham stated the procurement was determined after approval by the Nationwide Pharmaceutical Regulatory Company.
“Our view is that the AstraZeneca vaccine is helpful to be used by sure teams…(we) must have extra manufacturers of vaccine as some individuals could also be suitable with this vaccine,” he stated.
An announcement could be made on Monday on the primary group of recipients.
Malaysia has secured a complete of 12.8 million doses from AstraZeneca, half of which can come through the worldwide COVAX facility. It was slated to obtain the primary 600,000 doses in June.
(Reporting by Liz Lee; Modifying by Jacqueline Wong)
Copyright 2021 Thomson Reuters.